Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs.

Stanislav PantelyushinElisabeth RanningerDiego GuerreraGregor HutterCaroline Maake Enni Markkanen Regula Bettschart-Wolfensberger Carla Rohrer Bley Heinz Laubli Johannes Vom Berg

Published in: Cancers (2021)

Cross-functionality of atezolizumab encourages reverse translational efforts using (combination) immunotherapies in companion dog tumor patients to benefit both veterinary and human medicine.

Keyphrases

endothelial cells
end stage renal disease
induced pluripotent stem cells
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
angiotensin ii